$LUCY

Cohen David Eric sold $15K of LUCY

Cohen David Eric (Chief Technology Officer) sold 15,769 shares of Innovative Eyewear Inc (LUCY) at an average of $0.93 ($0.68–$1.17) across 4 trades over 2026-04-02 to 2026-08-19.

Original reporting
SEC EDGAR · Cohen David Eric
Published Aug 24, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 24, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LUCY
Neutral
high confidence
Mentioned
$LUCY
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LUCYNeutralLow
01

Why it matters

The transaction represents a modest reduction in insider ownership with no immediate price impact.

02

Market read

Low relevance; routine insider sale of a small amount.

03

What to watch

Potential upcoming dilution or financing events not disclosed in this filing.

Relevance 3/10Novelty 3/10Timing: filing date 2026-08-24

Background

Form 4 filings disclose insider transactions; this is a routine sale by the CTO.

Company-level read

Ticker impact

$LUCYNeutralHigh confidence
Context

CTO Cohen David Eric sold 15,769 shares of Innovative Eyewear Inc for $14,587 (≈$0.93 per share) in a Form 4 filing.

Expected impact

minimal impact; price likely unchanged

Evidence & confidence

Sale size is small relative to market cap and disclosed via a routine Form 4.

Market effects

None; insider sale does not affect eyewear sector broadly.

None; micro‑cap trade limited to US market.

None

Counterpoint

Even small insider sells can signal concerns; monitor subsequent insider activity.

Key entities

  • Innovative Eyewear Inc

    Issuer of ticker LUCY, micro‑cap eyewear manufacturer.

  • Cohen David Eric

    Chief Technology Officer of Innovative Eyewear Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LUCYMedAI 8/10

Top Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Update

Biotech gainers: Innovative Eyewear (LUCY) rose 63% after preliminary Q2 2026 net sales of ~$0.99M (+71% YoY) and new retail orders; Seer (SEER) jumped 35% on an unsolicited $2.45/share cash takeover proposal plus contingent value rights; Orthofix (OFIX) and Enovis (ENOV) gained 16%/15% after CMS withdrew reimbursement changes for non-invasive bone growth stimulators.